Table 2.
Measurement of quality-of-life scores (x ± s).
| Group | n | Physical function | Emotional function | Cognitive function | Social function | Role function | Total score | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | ||
| Joint group | 49 | 53.22 ± 4.90 | 82.69 ± 4.66∗△ | 53.20 ± 4.99 | 83.04 ± 5.01∗△ | 56.29 ± 4.56 | 84.37 ± 4.76∗△ | 54.29 ± 4.82 | 85.04 ± 4.46∗△ | 53.29 ± 5.32 | 82.86 ± 5.55∗△ | 54.18 ± 4.89 | 82.88 ± 5.35∗△ |
| Single-drug group | 49 | 54.27 ± 4.70 | 67.41 ± 4.88∗ | 53.90 ± 4.48 | 67.47 ± 4.70∗ | 57.47 ± 4.62 | 71.45 ± 4.83∗ | 55.12 ± 4.65 | 69.18 ± 4.17∗ | 54.31 ± 4.54 | 67.88 ± 4.99∗ | 54.71 ± 4.35 | 68.00 ± 4.56∗ |
| t | 1.073 | 15.86 | 0.724 | 15.87 | 1.277 | 13.34 | 0.875 | 18.18 | 1.021 | 14.06 | 0.568 | 14.82 | |
| P | 0.286 | ≤0.001 | 0.471 | ≤0.001 | 0.205 | ≤0.001 | 0.384 | ≤0.001 | 0.310 | ≤0.001 | 0.571 | ≤0.001 | |
∗P < 0.01 vs before treatment, △P < 0.01 vs joint group.